A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients

NCT06355258 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

COVID 19 Associated Coagulopathy

Interventions

DRUG: Troxerutin
DRUG: Placebo
DRUG: placebo + low molecular weight heparin
DRUG: troxerutin + low molecular weight heparin

Sponsor

Westlake University

Collaborators

[object Object]
[object Object]